Science: Switching to preservative-free glaucoma medications improves eye health and IOP control
Entering edit mode
4 months ago
david 4.2k

Simplified Abstract

Objective: Halting and reversing glaucoma therapy-related ocular surface disease (GTR-OSD) will improve the success of long-term medical therapy, impacting millions of patients worldwide.

Methods: A single-centre, masked, prospective, placebo-controlled, crossover trial of:

  • 41 well-controlled open-angle glaucoma subjects
    • with moderate to severe glaucoma therapy-related ocular surface disease (GTR-OSD)
    • on preserved latanoprost and dorzolamide/timolol fixed combination (DTFC) therapy

was conducted.

Results: Glaucoma therapy-related ocular surface disease (GTR-OSD) improved with preservative-free therapy.

Conclusions: Changing from preserved to PF glaucoma medications improves ocular surface health and IOP control. Topical cyclosporine 0.1% further reverses GTR-OSD.

rx:medications preservative-free glaucoma • 82 views

Login before adding your answer.

Traffic: 12 users visited in the last hour

Use of this site constitutes acceptance of our User Agreement and Privacy Policy.